Follistatin peptide stands as a critical reagent in advanced laboratory research, particularly for studies involving myostatin inhibition and cellular growth factor modulation. This sourcing guide focuses on high-purity follistatin peptide, typically offered at ≥98% purity verified by HPLC and mass spectrometry, ensuring batch-to-batch consistency for reproducible formulation. Manufacturing follows strict cGMP protocols in ISO-certified facilities, with comprehensive Certificates of Analysis (CoA) detailing purity, endotoxin levels, and residual solvent profiles. Key applications include in vitro cell culture assays and biochemical pathway investigations. Quality advantages include lyophilized powder stability and sterile filtration, eliminating common buyer pain points such as inconsistent solubility, low bioactivity, or incomplete documentation. By prioritizing verified manufacturing certifications and transparent purity data, researchers can avoid supply chain risks and formulation failures, securing reliable follistatin peptide for precise experimental outcomes.
Target Keyword: follistatin peptide
Follistatin peptide is a bioactive protein that functions as a high-affinity binding agent for activin and other members of the TGF-β superfamily. For B2B buyers—including cosmetic formulation chemists, peptide research laboratories, and raw material wholesalers—the core value lies in its ability to modulate cellular signaling pathways with precision. This guide provides the technical specifications, purity benchmarks, and manufacturing certifications required for confident sourcing and lab formulation.
Understanding the molecular profile of follistatin peptide is essential for evaluating supplier quality and ensuring batch-to-batch consistency. The following technical indices define the minimum acceptable standards for professional laboratory and cosmetic use.
Industry data from the Peptide Therapeutics Foundation indicates that over 70% of peptide raw material failures in formulation are traceable to substandard purity or incorrect storage conditions. Reliable follistatin peptide sourcing must include a Certificate of Analysis (CoA) with HPLC chromatogram and MS verification.
Reproducible follistatin peptide production relies on solid-phase peptide synthesis (SPPS) followed by controlled refolding and multi-step purification. Each batch must undergo rigorous quality control to meet the demands of cosmetic and laboratory applications.
The manufacturing chain begins with SPPS using Fmoc chemistry, followed by cleavage, precipitation, and lyophilization. Refolding is performed under optimized redox conditions to achieve the correct disulfide bridge pattern. Final purification employs reversed-phase HPLC with a C18 column, ensuring removal of truncated sequences and by-products.
Independent laboratories verify identity via amino acid analysis and peptide mapping. Bioactivity is confirmed using an activin-binding ELISA assay. All results are compiled into a comprehensive CoA that accompanies each shipment.
Follistatin peptide serves distinct roles across cosmetic formulation, laboratory research, and bulk wholesale channels. Each scenario demands specific purity grades and documentation.
In anti-aging serums and topical creams, follistatin peptide is incorporated at 0.1–1.0% concentration. Formulators require ≥95% purity, low endotoxin, and compatibility with common emulsifiers. The peptide supports the modulation of activin signaling, contributing to skin firmness and texture improvement.
Academic and biotech laboratories use follistatin peptide for cell culture studies, particularly in myogenesis, neuroprotection, and fibrosis models. Research-grade material (≥98% purity) with full bioactivity data is essential for reproducible results.
Wholesale buyers typically order 1–100 grams per batch. They prioritize consistent pricing, rapid lead times (2–4 weeks), and complete documentation including CoA, MSDS, and stability data. Long-term supply agreements often include batch reservation and custom packaging.
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity (HPLC) | ≥98% | 80–90% | Higher purity reduces side reactions and improves formulation consistency |
| Endotoxin Level | ≤0.1 EU/mg | 1–5 EU/mg | Lower endotoxin ensures safety for sensitive cell-based assays |
| Bioactivity Assay | Activin-binding ELISA verified | Not routinely tested | Functional validation guarantees intended signaling modulation |
| Documentation | Full CoA, MSDS, stability report | Basic CoA only | Complete traceability supports regulatory compliance and audit readiness |
Buyers sourcing follistatin peptide in bulk face common pitfalls that can compromise formulation quality and regulatory standing. This guide outlines selection standards and a practical checklist.
Prioritize suppliers who provide batch-specific CoA with HPLC trace, MS confirmation, and bioactivity data. Request a sample (10–50 mg) for in-house testing before committing to large volumes. Verify that the supplier can deliver consistent quality across multiple batches.
Our follistatin peptide offers distinct benefits for B2B buyers focused on formulation reliability and cost efficiency.
Purity: Every batch is tested by HPLC and MS, guaranteeing ≥98% purity with full chromatographic documentation. This eliminates variability and ensures consistent performance across applications.
Stability: Lyophilized formulation maintains integrity for 24 months at -20°C. Accelerated stability studies confirm less than 2% degradation over 12 months under recommended storage.
Cost Performance: Competitive bulk pricing without compromising quality. Our direct manufacturing model reduces intermediary costs, passing savings to wholesale buyers.
Technical Support: Dedicated application scientists assist with formulation optimization, solubility troubleshooting, and regulatory documentation. This partnership accelerates product development and reduces time-to-market.
Q: What is the minimum purity required for follistatin peptide in cosmetic formulations?
A: For cosmetic use, a minimum purity of 95% by HPLC is recommended. Higher purity (≥98%) is preferred for premium formulations where minimal impurities are critical for stability and skin compatibility.
Q: How should follistatin peptide be stored after reconstitution?
A: Reconstituted follistatin peptide should be stored at 4°C and used within 7 days. For longer storage, aliquot and freeze at -20°C for up to 3 months. Avoid repeated freeze-thaw cycles to maintain bioactivity.
Q: What certifications should I look for when sourcing follistatin peptide for lab research?
A: For lab research, ensure the supplier provides ISO 9001 certification, a detailed CoA with HPLC and MS data, endotoxin analysis, and bioactivity assay results. GMP compliance is an additional indicator of manufacturing rigor.